Xiehe Yixue Zazhi (Sep 2022)

Annual Research Progress of Glioma in China in 2021

  • CHEN Wenlin,
  • WANG Yaning,
  • XING Hao,
  • LIANG Tingyu,
  • SHI Yixin,
  • WANG Hai,
  • YANG Huiyu,
  • LIU Qianshu,
  • LI Junlin,
  • GUO Xiaopeng,
  • WANG Yu,
  • MA Wenbin

DOI
https://doi.org/10.12290/xhyxzz.2022-0235
Journal volume & issue
Vol. 13, no. 5
pp. 760 – 767

Abstract

Read online

Glioma, the most prevalent primary malignant tumor of the central nervous system, has a high degree of malignancy and poor prognosis for patients. At present, the researches of glioma mainly focus on the investigation of the mechanism of tumor occurrence and the discovery of new therapeutic methods and agents. In-depth researches have also been conducted on the optimization of molecular pathological typing of glioma, improvement of diagnostic imaging techniques and formulation of comprehensive treatment guidelines. In this review, we summarize the achievements and important progress made by Chinese medical scientists in the field of glioma in 2021, and propose possible future research directions with the aim of providing reference for clinical research.

Keywords